Who is sponsoring NCT04626037?

NCT04626037 is sponsored by Columbia University.

What drugs are being tested in NCT04626037?

Interventions in NCT04626037: WECS Relational Toolkit.

What condition does NCT04626037 study?

NCT04626037 studies Emotional Connection, Child Development, Primary Prevention, Disruptive Behavior.

Is NCT04626037 still recruiting?

NCT04626037 is currently completed. Last updated 21 November 2024.

Last reviewed 2024-11-21 · How we verify

NCT04626037

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CLC Parent-Child Emotional Preparation Program

Completed NA Last updated 21 November 2024

What this trial tests

NA trial testing WECS Relational Toolkit in Emotional Connection in 109 participants. Completed in 1 November 2023.

Timeline

9 April 2021

Primary endpoint
22 April 2022

1 November 2023

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	109
Start date	9 April 2021
Primary completion	22 April 2022
Estimated completion	1 November 2023
Sites	1 location across United States

Drugs / interventions tested

WECS Relational Toolkit

Conditions studied

Emotional Connection — all drugs for Emotional Connection →
Child Development — all drugs for Child Development →
Primary Prevention — all drugs for Primary Prevention →
Disruptive Behavior — all drugs for Disruptive Behavior →

Sponsor

Columbia University

Who can join

Under 5, any sex, with Emotional Connection or Child Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the feasibility of the Nurture Science Program's (NSP) Drop-In group via telemedicine as standard care at Children's Learning Centers (CLC) to prepare preschoolers emotionally for the preschool experience utilizing the Welch Emotional Connection Screen (WECS) Relational Health Toolkit. The behavioral, neurobiological, and clinical insights gained from this project may lead to better treatment of emotional, behavioral and developmental disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04626037 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 21 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04626037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing